BERKELEY HEIGHTS, N.J., May 8, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders will announce first quarter 2012 financial results on Monday 14, 2012. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
